Immunome
Edit

Immunome

http://immunome.com/
Last activity: 03.07.2023
Categories: HumanInformationPlatform
Immunome leverages the information stored in memory B cells to guide our discovery of first-in-class antibody therapeutics directed at potentially novel targets. Our Approach Leverages broad and deep interrogation of “highly-educated” B cells from patients who have learned how to fight off their disease. Enables the simultaneous discovery of novel … Read More
Mentions
5
Location: United States, Pennsylvania, Exton
Total raised: $25.5M

Investors 2

Funding Rounds 2

DateSeriesAmountInvestors
01.08.2020-$13.3M-
10.10.2016Series A$12.2M-

Mentions in press and media 5

DateTitleDescriptionSource
03.07.2023Startup led by former Seagen CEO Clay Siegall merges with pu...Clay Siegall. (Seagen Photo) Morphimmune, a biotech company led by former Seagen CEO Clay Siegall, ...geekwire.c...
20.05.2021IMMUNOME, INC. Immunome : Announces Additional $4.3 Million...Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell dis...marketscre...
20.05.2021IMMUNOME, INC. Immunome : Announces Additional $4.3 Million...Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Resul...marketscre...
23.03.2021Immunome Advances Its Proprietary Antibody Against IL-38, a ...EXTON, Pa.--(BUSINESS WIRE)--Mar 23, 2021-- Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical comp...oaoa.com/n...
10.10.2016Immunome Raises $12.2M in Additional Series A FinancingImmunome, Inc., a Philadelphia, PA-based biotechnology company focused on developing immunotherapies...finsmes.co...

Reviews 0

Sign up to leave a review

Sign up Log In